U.S. Senate Hearing on the Dangers of Chemical Abortion Drugs

The U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing this week examining the real and growing dangers of chemical abortion drugs—particularly mifepristone, the first drug in the abortion pill regimen.

Committee Chair Senator Bill Cassidy, M.D. (R-LA), opened the hearing by highlighting the trauma and serious injuries many women have suffered after taking the abortion pill—harm often dismissed after women were assured the drug was “safe.”

Louisiana Attorney General Liz Murrill testified that the Biden Administration, through the FDA, has deliberately undermined the Supreme Court’s Dobbs decision by allowing abortion pills to be distributed nationwide by mail. She argued this policy is unlawful, medically irresponsible, and has resulted in real harm to women and the unborn—especially in pro-life states like Louisiana.

The committee also heard testimony from Dr. Chireau Wubbenhorst of the University of Notre Dame, who detailed the ethical and medical dangers associated with chemical abortion drugs.

In contrast, Dr. Nisha Verma of Physicians for Reproductive Health defended mifepristone, insisting that “the science is settled” on its safety and effectiveness.

That phrase alone should raise red flags. When politicians or activists declare “the science is settled,” it usually signals ideology, not honesty. The growing evidence of harm, coercion, and abuse should give any sincere advocate for women serious pause.